Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Trogarzonon Dec 13, 2022 9:59am
53 Views
Post# 35168197

RE:Th is a stupid buy now

RE:Th is a stupid buy nowYes it's aggravating for normal people and smart investors to see such spudidy dragging down the price of our long term investement.  All of this on small volume.. and why ... because you paused your trial... a pause of a non factored in asset in analyst target equals a 50% price drop.   It's insulting to intelligence and at the same time it's aggravating seing this unvail under your incapable eyes.  If I call IR I will be told but what can we do.  Listen if you can't get the thing to be worth one time sales there is a problem.  I think there is a problem and I thing soemthing should be done to get value back to normal levels considering the facts and that is about 3$ atm.
<< Previous
Bullboard Posts
Next >>